Mirati Therapeutics

YTD

ALL

Why Robinhood?

You can watch MRTX and buy or sell other stocks, ETFs, and their options commission-free!

About MRTX

Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer.

CEO

Charles M. Baum, MD, PhD

CEOCharles M. Baum, MD, PhD

Employees

—

Employees—

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1995

Founded1995

Employees

—

Employees—

MRTX Key Statistics

Market cap

4.12B

Market cap4.12B

Price-Earnings ratio

-4.80

Price-Earnings ratio-4.80

Dividend yield

—

Dividend yield—

Average volume

2.31M

Average volume2.31M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$64.41

52 Week high$64.41

52 Week low

$27.30

52 Week low$27.30

People also own

Based on the portfolios of people who own MRTX. This list is generated using Robinhood data, and it’s not a recommendation.